A Study of Irinotecan and Cetuximab With or Without IMC-A12 for Treatment of Participants With Colon or Rectum Cancer Who Got Worse After Their First Treatment With Oxaliplatin and Bevacizumab
Part of paid clinical trials in Vallejo, California.
- Sponsor
- Eli Lilly and Company
- Study ID
- NCT00845039
- Phase
- PHASE2
- Status
- Terminated
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Cetuximab — BIOLOGICALCetuximab 500 mg/m² every 14 days until disease progression or participant intolerance
- Irinotecan — DRUG180 mg/m² every 14 days until disease progression or participant intolerance
- IMC-A12 (cixutumumab) — BIOLOGICALIMC-A12 10 mg/kg every 14 days until disease progression or participant intolerance
Study Details
The purpose of this study is to determine the value of adding IMC-A12 to irinotecan and cetuximab in participants with metastatic colorectal cancer (CRC).
Key Dates
- Start date
- May 31, 2009
- Status verified
- Jun 2018
- Primary completion
- Feb 28, 2011
- Completion
- Feb 28, 2011
Study Design
- Enrollment
- 4 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Cetuximab + IrinotecanParticipants in Treatment Group 1 will receive intravenous infusions of Cetuximab 500 milligrams per square meter (mg/m²) and Irinotecan 180 mg/m².
- Experimental: Cetuximab + IMC-A12 + IrinotecanParticipants in Treatment Group 2 will receive intravenous infusions of Cetuximab 500 mg/m², IMC-A12 10 milligrams/kilogram (mg/kg) and Irinotecan 180 mg/m².
Primary Outcome Measure
Progression-Free Survival (PFS) Rate at 18 Weeks [ Time Frame: Approximately 18 Weeks ]
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| ImClone Investigational Site | Vallejo | California | 94589 | - |
| ImClone Investigational Site | Greenville | North Carolina | 27834 | - |
| ImClone Investigational Site | Scranton | Pennsylvania | 18510 | - |
Find similar trials in Vallejo, CA
By condition
By specialty
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsPHASE2 · Recruiting · Apollomics Inc. · Los Angeles, California
- Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal CancerPHASE1/PHASE2 · Recruiting · Washington University School of Medicine · Orange, California
- The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyRecruiting · UMC Utrecht · Pittsburgh, Pennsylvania